MFIM
SGMO

Mesirow Financial Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Mesirow Financial Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,800
Closed -$7.95K – 549
2025
Q3 		$7.95K Hold
11,800
– – ﹤0.01% 554
2025
Q2 		$6.39K Hold
11,800
– – ﹤0.01% 535
2025
Q1 		$7.74K Hold
11,800
– – ﹤0.01% 590
2024
Q4 		$12K Hold
11,800
– – ﹤0.01% 593
2024
Q3 		$10.2K Buy
+11,800
New +$8.64K ﹤0.01% 591

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mesirow Financial Investment Management's SGMO Position: Q4 2025 in Review

Mesirow Financial Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 11,800 shares — an estimated $7.95K sold.

Mesirow Financial Investment Management first reported a position in SGMO in Q3 2024 and held it in 5 quarters. The position peaked at $12K in Q4 2024. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Mesirow Financial Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 11,800 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $7.95K.
  • Mesirow Financial Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2024 and held it in 5 quarters.
  • Mesirow Financial Investment Management's SANGAMO THERAPEUTICS INC position peaked at $12K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.